跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Peldacyn - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Peldacyn
Approved
STANDARD
Peldacyn
Samjin Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cfa18d4cab3c86d3
Company
Samjin Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
cfa18d4cab3c86d3
Drug Approval Philippines Name
Peldacyn
Product Name
Peldacyn
Registration Number
DR-XY41979
Brand Name
Peldacyn
Generic Name
Clindamycin (As Phosphate)
Dosage Form
Solution for Injection (I.M./I.V.)
Dosage Strength
150 mg/mL
Manufacturer
Samjin Pharmaceutical Co., Ltd.
Importer
Natrapharm, Inc.
Distributor
Natrapharm, Inc.
Company Detail Path
/organization/samjin-pharmaceutical-co-ltd
Issuance Date
31 March 2022
Expiry Date
29 April 2026
Pharmacologic Category
Antibacterial (Lincosamide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cfa18d4cab3c86d3
Type
Standard
Back to Philippines FDA Approvals